Home › Companies › 89BIO INC. › 2023-2024

89BIO INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and 89BIO INC.’s Form 8-K, filed 2024-05-31 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 8Reported items
  • 168Asset managers
  • 1,179Fund votes
  • 2024-05-29Meeting date

Proxy season: 2023-2024 2024-2025

Explore 89BIO INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by 89BIO INC.

These tallies are 89BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-31 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

89BIO INC. — official shareholder meeting results, meeting held 2024-05-29
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: • Steven M. Altschuler, M.D. 78,767,873---- 870,3065,519,919 Majority: yes
Elect Director: • Michael Hayden, M.B. Ch.B., Ph.D. 74,810,576---- 4,827,6035,519,919 Majority: yes
Elect Director: • Kathleen LaPorte 41,297,162---- 38,341,0175,519,919 Majority: yes

Source: 89BIO INC., Form 8-K, filed with the SEC on 2024-05-31 — read the filing on EDGAR.

How asset managers voted at the 89BIO INC. 2023-2024 meeting

Each item below shows how the 168 asset managers that disclosed a 89BIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of 89BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. APPROVAL OF, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 162 asset managers below cast 98% of the shares they voted on this item FOR (84,359,885 for, 1,358,953 against).

FOR: 84,359,885 (98.4%)AGAINST: 1,358,953 (1.6%)
Largest asset managers voting on “APPROVAL OF, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at 89BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Janus Henderson11,894,5750 00For
RA CAPITAL MANAGEMENT, L.P.11,105,7320 00For
State Street7,684,8540 00For
SUVRETTA CAPITAL MANAGEMENT, LLC5,837,3710 00For
BlackRock5,086,1720 00For
JANUS INVESTMENT FUND5,001,3960 00For
Vanguard4,730,6210 00For
RTW INVESTMENTS, LP4,491,7270 00For
BVF INC/IL4,006,5760 00For
PICTET ASSET MANAGEMENT SA3,400,4260 00For
Laurion Capital Management LP2,349,8270 00For
Redmile Group, LLC2,054,4660 00For
WESTFIELD CAPITAL MANAGEMENT CO LP1,667,0440 00For
Charles Schwab1,264,0620 00For
GEODE CAPITAL MANAGEMENT, LLC1,185,4070 00For
Fidelity1,116,5550 00For
HARBOR FUNDS1,004,7470 00For
MPM BioImpact LLC980,9780 00For
Holocene Advisors, LP975,3880 00For
Aberdeen0940,774 00Against
FRANKLIN ADVISERS INC827,3710 00For
Citadel644,1210 00For
Nuveen557,9080 00For
Northern Trust489,40780 00For
TIAA459,8720 00For

Showing the 25 largest of 162 asset managers. See all 162 in the interactive database.

2. ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

13%ONE YEAR 73%10%

The 160 asset managers below cast 100% of the shares they voted on this item FOR (38,589 for, 0 against).

FOR: 38,589 (0.0%)ABSTAIN: 11,105,732 (13.0%)ONE YEAR: 62,347,414 (72.8%)1 YEAR: 8,197,111 (9.6%)1-YR: 4,006,576 (4.7%)3 YEARS: 500 (0.0%)
Largest asset managers voting on “ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION.” at 89BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Janus Henderson00 00One Year
RA CAPITAL MANAGEMENT, L.P.00 11,105,7320Abstain
State Street00 00One Year
SUVRETTA CAPITAL MANAGEMENT, LLC00 00One Year
BlackRock00 00One Year
JANUS INVESTMENT FUND00 00One Year
Vanguard00 00One Year
RTW INVESTMENTS, LP00 00One Year
BVF INC/IL00 001-Yr
PICTET ASSET MANAGEMENT SA00 00One Year
Laurion Capital Management LP00 00One Year
Redmile Group, LLC00 001 Year
WESTFIELD CAPITAL MANAGEMENT CO LP00 00One Year
Charles Schwab00 001 Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
Fidelity00 00One Year
HARBOR FUNDS00 001 Year
MPM BioImpact LLC00 001 Year
Holocene Advisors, LP00 001 Year
Aberdeen00 00One Year
FRANKLIN ADVISERS INC00 00One Year
Citadel00 00One Year
Nuveen00 00One Year
Northern Trust00 001 Year
TIAA00 00One Year

Showing the 25 largest of 160 asset managers. See all 160 in the interactive database.

3. Election of Directors: To be elected for terms expiring in 2027: Kathleen LaPorte

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

51.9% Majority: yes · of votes cast

FOR 51.9%WITHHELD 48.1%
FOR: 41,297,162WITHHELD: 38,341,017

89BIO INC.’s own tally for this item (“Elect Director: • Kathleen LaPorte”): 41,297,162 for, 38,341,017 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 95,199,724 outstanding shares: 43% for, 40% withheld (84% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (8,262,397 for, 0 against).

FOR 39%ABSTAIN 61%
FOR: 8,262,397 (38.8%)ABSTAIN: 13,010,423 (61.2%)
Largest asset managers voting on “Election of Directors: To be elected for terms expiring in 2027: Kathleen LaPorte” at 89BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND2,003,0630 2,998,3330Abstain
Vanguard4,515,2160 00For
State Street34,6560 3,213,1210Abstain
BlackRock00 2,926,9020Abstain
Fidelity1,075,1630 38,7880For
HARBOR FUNDS3,5870 1,001,1600Abstain
Charles Schwab00 632,0310Abstain
Aberdeen00 470,3870Abstain
TIAA459,8720 00For
FRANKLIN STRATEGIC SERIES00 254,2370Abstain
Direxion Shares ETF Trust00 247,6800Abstain
CARILLON SERIES TRUST00 206,9530Abstain
Equitable00 198,3390Abstain
Goldman Sachs00 138,3990Abstain
QUANTITATIVE MASTER SERIES LLC00 112,7830Abstain
ProShares00 92,6520Abstain
Nushares ETF Trust87,9140 00For
Lincoln Financial00 78,4800Abstain
Morgan Stanley00 44,3000Abstain
Harbor Funds II43,5410 00For
Northern Trust00 40,4340Abstain
AIG/SunAmerica00 38,9680Abstain
Global X00 28,3090Abstain
John Hancock00 27,7210Abstain
Pacific Life00 26,3970Abstain

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

4. Election of Directors: To be elected for terms expiring in 2027: Michael Hayden, M.B. Ch.B., Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 74,810,576WITHHELD: 4,827,603

89BIO INC.’s own tally for this item (“Elect Director: • Michael Hayden, M.B. Ch.B., Ph.D.”): 74,810,576 for, 4,827,603 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 95,199,724 outstanding shares: 79% for, 5% withheld (84% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (18,103,380 for, 0 against).

FOR 85%ABSTAIN 15%
FOR: 18,103,380 (85.1%)ABSTAIN: 3,169,440 (14.9%)
Largest asset managers voting on “Election of Directors: To be elected for terms expiring in 2027: Michael Hayden, M.B. Ch.B., Ph.D.” at 89BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND5,001,3960 00For
Vanguard4,515,2160 00For
State Street135,4350 3,112,3420Abstain
BlackRock2,926,9020 00For
Fidelity1,113,9510 00For
HARBOR FUNDS1,004,7470 00For
Charles Schwab632,0310 00For
Aberdeen470,3870 00For
TIAA459,8720 00For
FRANKLIN STRATEGIC SERIES254,2370 00For
Direxion Shares ETF Trust247,6800 00For
CARILLON SERIES TRUST206,9530 00For
Equitable198,3390 00For
Goldman Sachs138,3990 00For
QUANTITATIVE MASTER SERIES LLC112,7830 00For
ProShares92,6520 00For
Nushares ETF Trust87,9140 00For
Lincoln Financial26,3800 52,1000Abstain
Morgan Stanley44,3000 00For
Harbor Funds II43,5410 00For
Northern Trust40,4340 00For
AIG/SunAmerica38,9680 00For
Global X28,3090 00For
John Hancock27,7210 00For
Pacific Life26,3970 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

5. Election of Directors: To be elected for terms expiring in 2027: Steven Altschuler, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 78,767,873WITHHELD: 870,306

89BIO INC.’s own tally for this item (“Elect Director: • Steven M. Altschuler, M.D.”): 78,767,873 for, 870,306 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 95,199,724 outstanding shares: 83% for, 1.0% withheld (84% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (21,261,338 for, 0 against).

FOR 99.9%
FOR: 21,261,338 (99.9%)ABSTAIN: 11,482 (0.1%)
Largest asset managers voting on “Election of Directors: To be elected for terms expiring in 2027: Steven Altschuler, M.D.” at 89BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND5,001,3960 00For
Vanguard4,515,2160 00For
State Street3,244,1810 3,5960For
BlackRock2,926,9020 00For
Fidelity1,113,9510 00For
HARBOR FUNDS1,004,7470 00For
Charles Schwab632,0310 00For
Aberdeen470,3870 00For
TIAA459,8720 00For
FRANKLIN STRATEGIC SERIES254,2370 00For
Direxion Shares ETF Trust247,6800 00For
CARILLON SERIES TRUST206,9530 00For
Equitable198,3390 00For
Goldman Sachs138,3990 00For
QUANTITATIVE MASTER SERIES LLC112,7830 00For
ProShares92,6520 00For
Nushares ETF Trust87,9140 00For
Lincoln Financial78,4800 00For
Morgan Stanley44,3000 00For
Harbor Funds II43,5410 00For
Northern Trust40,4340 00For
AIG/SunAmerica38,9680 00For
Global X28,3090 00For
John Hancock27,7210 00For
Pacific Life26,3970 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

6. Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 49 asset managers below cast 100% of the shares they voted on this item FOR (21,272,820 for, 0 against).

FOR: 21,272,820 (100.0%)
Largest asset managers voting on “Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ” at 89BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND5,001,3960 00For
Vanguard4,515,2160 00For
State Street3,247,7770 00For
BlackRock2,926,9020 00For
Fidelity1,113,9510 00For
HARBOR FUNDS1,004,7470 00For
Charles Schwab632,0310 00For
Aberdeen470,3870 00For
TIAA459,8720 00For
FRANKLIN STRATEGIC SERIES254,2370 00For
Direxion Shares ETF Trust247,6800 00For
CARILLON SERIES TRUST206,9530 00For
Equitable198,3390 00For
Goldman Sachs138,3990 00For
QUANTITATIVE MASTER SERIES LLC112,7830 00For
ProShares92,6520 00For
Nushares ETF Trust87,9140 00For
Lincoln Financial78,4800 00For
Morgan Stanley44,3000 00For
Harbor Funds II43,5410 00For
Northern Trust40,4340 00For
AIG/SunAmerica38,9680 00For
Global X28,3090 00For
John Hancock27,7210 00For
Pacific Life26,3970 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

7. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

1-YEAR 99.5%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1-YEAR: 450,000 (99.6%)ONE YEAR: 1,866 (0.4%)
Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at 89BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ADAGE CAPITAL PARTNERS GP, L.L.C.00 001-Year
Desjardins Global Asset Management Inc.00 00One Year

8. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

99.5% fund support · no official result

FOR 99.5%

The 2 asset managers below cast 99.5% of the shares they voted on this item FOR (450,000 for, 1,866 against).

FOR: 450,000 (99.6%)AGAINST: 1,866 (0.4%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at 89BIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ADAGE CAPITAL PARTNERS GP, L.L.C.450,0000 00For
Desjardins Global Asset Management Inc.01,866 00Against

Largest 89BIO INC. shareholders voting in 2023-2024

Ranked by the number of 89BIO INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 95,199,724 shares outstanding at the time of that meeting.

Top 89BIO INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Janus Henderson 12.49%
2RA CAPITAL MANAGEMENT, L.P. 11.67%
3State Street 8.07%
4SUVRETTA CAPITAL MANAGEMENT, LLC 6.13%
5BlackRock 5.34%
6JANUS INVESTMENT FUND 5.25%
7Vanguard 4.97%
8RTW INVESTMENTS, LP 4.72%
9BVF INC/IL 4.21%
10PICTET ASSET MANAGEMENT SA 3.57%

Reported 89BIO INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

89BIO INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
Entities affiliated with RA Capital 14.97% DEF14A
BlackRock 10.84% 13F
Entities affiliated with Janus Henderson Group 10.59% DEF14A
Vanguard Group 8.46% 13F
S 8.39% 13G
Entities affiliated with RTW Investments, LP 5.86% DEF14A
State Street 5.82% 13F
Entities affiliated with Suvretta Capital Management, LLC. 5.13% DEF14A
Citadel Advisors 1.81% 13F
Goldman Sachs 1.70% 13F

Percentages above are of 95,199,724 shares outstanding, as reported by 89BIO INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from 89BIO INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At 89BIO INC.'s shareholder meeting held 2024-05-29, in the 2023-2024 proxy season, 168 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,179 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. 89BIO INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — APPROVAL OF, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. — the reporting funds cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

89BIO INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.